Results for "Understanding Pharmaceutical Distribution"
HDA Statement on Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released the following statement in response to the Senate Finance Committee hearing entitled, “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.”
HDA Names Bryan Hannon to State Government Affairs; Announces Five Promotions
The Healthcare Distribution Alliance (HDA) announced the following updates to its staff.
HDA Factbook: Prescription Sales Through Traditional Healthcare Distributors Remain Strong in 2023
New data released by the HDA Research Foundation reveal that total prescription sales through traditional pharmaceutical distributors grew by 13.7 percent in 2023.
Pharmaceutical Distributors are at the Forefront of Cold Chain Logistics
As the fight against the coronavirus pandemic continues, the successful development of effective COVID-19 vaccines will represent a pivotal moment in our country’s efforts to end this public health crisis. However, the discovery of a vaccine is just the first step of many to ensure these critical medicines are widely accessible to providers and their patients.
HDA Statement on the PREVENT Pandemics Act
The Healthcare Distribution Alliance (HDA) applauds the leadership of Senate Health, Education, Labor, and Pensions (HELP) Committee’s Chairwoman Murray (D-Wash.) and Ranking Member Burr (R-N.C.) for introducing the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act), a bipartisan public health effort to build stronger national medical preparedness and response systems in the wake of the COVID-19 pandemic. The overwhelming support for the legislation during the HELP Committee markup today, March 15, showed that Congress is making significant, positive steps towards reforms necessary to ensure the availability of lifesaving pharmaceutical treatments and medical supplies in response to future crises.